The p15 gene is a putative tumor suppressor gene that encodes a member of the cyclin dependent kinase inhibitors. Inactivation of p15 by promoter hypermethylation has been postulated as a possible way by which tumor suppressor genes are inactivated in cancer. In this study, we examined the methylation status of the p15 gene promoter in 34 patients with B-Chronic Lymphocytic Leukemia (B-CLL), by the Methylation-Specific Polymerase Chain Reaction. Selective methylation of the p15 gene promoter was found in 4/34 cases (11.8%). According to Rai staging, the four patients with methylated p15 were staged on diagnosis as: 1 on Stage 0, 1 in Stage I, 1 in Stage III, and 1 in Stage IV. Our results suggest that methylation of the p15 gene promoter can be detected in a small subset of B-CLL patients, at all stages of the disease. © 2007 Wiley-Liss, Inc.
CITATION STYLE
Papageorgiou, S. G., Lambropoulos, S., Pappa, V., Economopoulou, C., Kontsioti, F., Papageorgiou, E., … Economopoulos, T. (2007). Hypermethylation of the p15INK4B gene promoter in B-chronic lymphocytic leukemia. American Journal of Hematology, 82(9), 824–825. https://doi.org/10.1002/ajh.20914
Mendeley helps you to discover research relevant for your work.